Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
13 hedge funds and large institutions have $1.76M invested in Vaccinex, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$824K |
| 2 |
PA
Perceptive Advisors
New York
|
+$491K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$485K |
| 4 |
Bank of New York Mellon
New York
|
+$167K |
| 5 |
NC
Nexthera Capital
New York
|
+$167K |
Top Sellers
VCNX Hedge Fund Activity: Q3 2018 in Review
13 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2018, worth a combined $1.76M.
Buyers outnumbered sellers: 13 funds opened new VCNX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $824K.
- 13 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $1.76M of Vaccinex, Inc. Common Stock stock for Q3 2018.
- 13 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2018 and 0 closed out, a net change of +13 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q3 2018 was Millennium Management, an estimated $824K added.
Based on aggregated 13F filings for Q3 2018.